Market Research Logo

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 provides an overview of Liver Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Liver Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Liver Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Liver Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Liver Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Liver Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Liver Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
4 Liver Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Liver Cancer Companies - Pipeline Products by Stage of Development
4.2 Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
5 Liver Cancer Diagnostic Tests Companies and Product Overview
5.1 Abbott Diagnostics Company Overview
5.2 Abcodia Ltd Company Overview
5.3 AXO Science SAS Company Overview
5.4 BioMark Technologies Inc Company Overview
5.5 Bioprognos SL Company Overview
5.6 China Sky One Medical Inc Company Overview
5.7 Digna Biotech SL Company Overview
5.8 Exact Sciences Corp Company Overview
5.9 Fujirebio Diagnostics Inc Company Overview
5.10 German Cancer Research Center Company Overview
5.11 Glycotest Inc Company Overview
5.12 ImCare Biotech LLC Company Overview
5.13 Imperial College London Company Overview
5.14 IntegraGen SA Company Overview
5.15 Matrix-Bio, Inc. Company Overview
5.16 Medical University of South Carolina Company Overview
5.17 Medical University of Vienna Company Overview
5.18 NanoString Technologies Inc Company Overview
5.19 Oncimmune (USA) LLC Company Overview
5.20 Orion Genomics LLC Company Overview
5.21 PleX Diagnostics Inc (Inactive) Company Overview
5.22 ProMIS Neurosciences Inc Company Overview
5.23 Proplex Technologies Llc Company Overview
5.24 Proteome Sciences Plc Company Overview
5.25 Roche Diagnostics International Ltd Company Overview
5.26 University of Louisville Company Overview
5.27 University of Rochester Company Overview
5.28 Ventana Medical Systems Inc Company Overview
5.29 Viomics Inc. Company Overview
5.30 XEPTAGEN SpA Company Overview
5.31 Ymir Genomics LLC. Company Overview
6 Liver Cancer Diagnostic Tests - Recent Developments
6.1 Jun 22, 2018: Trovagene Announces Senior Management Change
6.2 Jun 06, 2018: Pfizer Opens Call for Proposals for Neuroscience Start-ups to Apply for LabCentral Residency
6.3 Jun 05, 2018: Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma
6.4 Jun 05, 2018: Mayo Clinic researchers take a step closer to developing a DNA test for liver cancer
6.5 May 14, 2018: Oncimmune Launches EarlyCDT-Liver Test in the US
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Liver Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Liver Cancer Companies - Pipeline Products by Stage of Development
Table 6: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 8: ARCHITECT c16000 System - PIVKA Assay - Product Status
Table 9: ARCHITECT c16000 System - PIVKA Assay - Product Description
Table 10: ARCHITECT c4000 System - PIVKA Assay - Product Status
Table 11: ARCHITECT c4000 System - PIVKA Assay - Product Description
Table 12: ARCHITECT c8000 System - PIVKA Assay - Product Status
Table 13: ARCHITECT c8000 System - PIVKA Assay - Product Description
Table 14: ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Status
Table 15: ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Description
Table 16: ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Status
Table 17: ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Description
Table 18: ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Status
Table 19: ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Description
Table 20: ARCHITECT i4000SR System - PIVKA II Assay - Product Status
Table 21: ARCHITECT i4000SR System - PIVKA II Assay - Product Description
Table 22: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Biomarker Test - Liver Cancer Diagnostic Tests - Product Status
Table 24: Biomarker Test - Liver Cancer Diagnostic Tests - Product Description
Table 25: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Multiplexed Detection - Des-Carboxy Prothrombin - Product Status
Table 27: Multiplexed Detection - Des-Carboxy Prothrombin - Product Description
Table 28: Multiplexed Detection - Matrix metalloproteinase 1 - Product Status
Table 29: Multiplexed Detection - Matrix metalloproteinase 1 - Product Description
Table 30: Multiplexed Detection - Procollagen type III N-terminal peptide - Product Status
Table 31: Multiplexed Detection - Procollagen type III N-terminal peptide - Product Description
Table 32: BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Biomarker Assay - Hepatocellular Cancer - Product Status
Table 34: Biomarker Assay - Hepatocellular Cancer - Product Description
Table 35: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
Table 36: MBDAA Liver Cancer Test - Product Status
Table 37: MBDAA Liver Cancer Test - Product Description
Table 38: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Diagnostic Kit - Liver Cancer Diagnostic Tests - Product Status
Table 40: Diagnostic Kit - Liver Cancer Diagnostic Tests - Product Description
Table 41: Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
Table 42: HCC Molecular Marker Assay - Product Status
Table 43: HCC Molecular Marker Assay - Product Description
Table 44: Oxidated APO-A1 Assay - Product Status
Table 45: Oxidated APO-A1 Assay - Product Description
Table 46: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Blood-based Liver Cancer Test - Product Status
Table 48: Blood-based Liver Cancer Test - Product Description
Table 49: DNA Biomarkers - Hepatocellular Carcinoma - Product Status
Table 50: DNA Biomarkers - Hepatocellular Carcinoma - Product Description
Table 51: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Lumipulse G - PIVKA-II Assay - Product Status
Table 53: Lumipulse G - PIVKA-II Assay - Product Description
Table 54: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 55: RAGE Based Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Status
Table 56: RAGE Based Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Description
Table 57: Glycotest Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 58: HCC Panel - Product Status
Table 59: HCC Panel - Product Description
Table 60: ImCare Biotech LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 61: HepatoDetect Diagnostic Kit - Product Status
Table 62: HepatoDetect Diagnostic Kit - Product Description
Table 63: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Diagnostic Assay - HCC - Product Status
Table 65: Diagnostic Assay - HCC - Product Description
Table 66: IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Diagnostic Test - Hepatocellular Carcinoma - Product Status
Table 68: Diagnostic Test - Hepatocellular Carcinoma - Product Description
Table 69: Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 70: VeraMarker LCS (Liver Cancer Screening) Test - Product Status
Table 71: VeraMarker LCS (Liver Cancer Screening) Test - Product Description
Table 72: VeraMarker Liver Cancer Screening Test - Hepatitis - Product Status
Table 73: VeraMarker Liver Cancer Screening Test - Hepatitis - Product Description
Table 74: Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Glycan-Based Biomarker Assay - Liver Cancer Diagnostic Tests - Product Status
Table 76: Glycan-Based Biomarker Assay - Liver Cancer Diagnostic Tests - Product Description
Table 77: Medical University of Vienna Pipeline Products & Ongoing Clinical Trials Overview
Table 78: sAXL Biomarker Test - Hepatocellular Carcinoma - Product Status
Table 79: sAXL Biomarker Test - Hepatocellular Carcinoma - Product Description
Table 80: NanoString Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 81: In Vitro Diagnostic Assay - HCC Gene Signature - Product Status
Table 82: In Vitro Diagnostic Assay - HCC Gene Signature - Product Description
Table 83: Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 84: EarlyCDT - Liver Cancer Kit - Product Status
Table 85: EarlyCDT - Liver Cancer Kit - Product Description
Table 86: Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Status
Table 88: Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Description
Table 89: PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 90: HCCpleX - Product Status
Table 91: HCCpleX - Product Description
Table 92: ProMIS Neurosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 93: Screening Test - Liver Cancer Diagnostic Tests - Product Status
Table 94: Screening Test - Liver Cancer Diagnostic Tests - Product Description
Table 95: Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Biomarker Diagnostic Test - Liver Cancer Diagnostic Tests - Product Status
Table 97: Biomarker Diagnostic Test - Liver Cancer Diagnostic Tests - Product Description
Table 98: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Biomarker Assay - Liver Cancer Diagnostic Tests - Product Status
Table 100: Biomarker Assay - Liver Cancer Diagnostic Tests - Product Description
Table 101: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Cobas 8000 Analyzer Series With e 801 Module - PIVKA Assay - Product Status
Table 103: Cobas 8000 Analyzer Series With e 801 Module - PIVKA Assay - Product Description
Table 104: Glypican-3 MAb Companion Diagnostic Test - Product Status
Table 105: Glypican-3 MAb Companion Diagnostic Test - Product Description
Table 106: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
Table 107: Diagnostic Test - Hepatocellular Carcinoma - Product Status
Table 108: Diagnostic Test - Hepatocellular Carcinoma - Product Description
Table 109: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
Table 110: Biomarker Test - HCC - Product Status
1.2 List of Figures
Figure 1: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Liver Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report